Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 30414/0008.
ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion
ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion
Esmolol hydrochloride
1. What ESMOLOL HYDROCHLORIDE 2500 mg powder is and what it is used for
2. What you need to know before you use ESMOLOL HYDROCHLORIDE 2500 mg powder
3. How to use ESMOLOL HYDROCHLORIDE 2500 mg powder
4. Possible side effects
5. How to store ESMOLOL HYDROCHLORIDE 2500 mg powder
6. Contents of the pack and other information
ESMOLOL HYDROCHLORIDE 2500 mg powder belongs to the group of beta blockers these medicines slow down the heart beat and reduce blood pressure.
ESMOLOL HYDROCHLORIDE 2500 mg powder is used for short term treatment if your heart beats too fast.
ESMOLOL HYDROCHLORIDE 2500 mg powder is also used during or straight after surgery if your blood pressure gets too high and/or your heart beats too fast.
ESMOLOL HYDROCHLORIDE 2500 mg powder MUST BE RECONSTITUTED/DILUTED BY YOUR DOCTOR OR NURSE
Talk to your doctor or nurse before being given ESMOLOL HYDROCHLORIDE 2500 mg powder. Your doctor will take special care with this medicine if
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription, herbal medicines, or natural products. Your doctor will check that any medicines you are taking will not alter the way that ESMOLOL HYDROCHLORIDE 2500 mg powder works.
In particular, tell your doctor or nurse if you are taking any of the following:
If you are not sure if any of the above applies to you, talk to your doctor or nurse before having ESMOLOL HYDROCHLORIDE 2500 mg powder.
The use of medicines such as ESMOLOL HYDROCHLORIDE 2500 mg powder over a long period of time can cause a reduction in the force of your heartbeat.
Since ESMOLOL HYDROCHLORIDE is only used for a limited time, this is unlikely to happen to you. During treatment you will be carefully monitored and ESMOLOL HYDROCHLORIDE 2500 mg powder treatment will be reduced or stopped if the force of your heartbeat is reduced.
Your doctor will also check your blood pressure while you are being treated with ESMOLOL HYDROCHLORIDE 2500 mg powder.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Insufficient data are available about the use of ESMOLOL HYDROCHLORIDE 2500 mg powder during pregnancy in humans to prove safety. However, there are no indicators of increased risk of birth defects in humans.
Because of the lack of experience the use of ESMOLOL HYDROCHLORIDE 2500 mg powder during pregnancy is not recommended.
Tell your doctor if you are breast-feeding. ESMOLOL HYDROCHLORIDE 2500 mg powder may pass into breast milk, so you should not be given ESMOLOL HYDROCHLORIDE 2500 mg powder if you are breast-feeding.
Ask your doctor or nurse for advice before taking any medicine.
ESMOLOL HYDROCHLORIDE 2500 mg powder MUST BE RECONSTITUTED/DILUTED BEFORE ADMINISTRATION
The dosage must be individually adapted. A starting dosage followed by a maintenance dosage should be administered. Your doctor will determine the dosage scheme and adapt the dosage as needed based on the side effects.
ESMOLOL HYDROCHLORIDE 2500 mg powder is administered as an infusion. It is administered into a vein by a doctor or a nurse. The administration of the 50 mg/ml solution using a perfusor pump should be strictly done in a large vein or in a central catheter.
The duration of use depends on the effect and possibly occurring side effects. Your doctor will determine the duration of treatment.
Changing the dose of ESMOLOL HYDROCHLORIDE 2500 mg powder is not usually necessary if you:
If you have kidney problems then your doctor will take appropriate caution.
Your doctor will start your treatment with a lower dose.
The safety and efficacy of ESMOLOL HYDROCHLORIDE 2500 mg powder have not been established in children and adolescents. Children up to the age of 18 years should not receive ESMOLOL HYDROCHLORIDE 2500 mg powder.
As you are being given ESMOLOL HYDROCHLORIDE 2500 mg powder by a trained and qualified person, it is unlikely that you will have too much. However, if this happens the doctor will stop ESMOLOL HYDROCHLORIDE 2500 mg powder and give you additional treatment, if necessary.
As you are being given ESMOLOL HYDROCHLORIDE 2500 mg powder by a trained and qualified person, it is unlikely that you will miss a dose. However, if you think that you have missed a dose, talk to your doctor or nurse as soon as possible.
Suddenly stopping ESMOLOL HYDROCHLORIDE 2500 mg powder may cause symptoms of rapid heartbeat (tachycardia) and high blood pressure (hypertension) to return. To avoid this your doctor should stop your treatment gradually. If you are known to have coronary artery disease (this may be associated with a history of angina or heart attack) your doctor will take special care when stopping treatment with ESMOLOL HYDROCHLORIDE 2500 mg powder.
If you have any further questions on the use of this product, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most side effects disappear within 30 minutes of stopping treatment with ESMOLOL HYDROCHLORIDE 2500 mg powder. The following side effects have been reported with ESMOLOL HYDROCHLORIDE 2500 mg powder:
Tell your doctor or nurse straight away if you notice any of the following side effects, which can be serious. The infusion may also need to be stopped.
Very common (may affect more than 1 in 10 people):
Common (may affect less than 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Very rare (may affect up to 1 in 10,000 people):
Not known (the number of people affected is unknown):
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
The in-use storage condition is 25°C.
The opened, reconstituted and diluted product is physicochemically stabile during 24 hours at 25 °C. From microbiological point of view the product must be used immediately after opening and dilution. In case this is not done, the user is responsible for use and administration. Normally, the period of use is not more than 24 hours at 2-8 °C, unless opening, reconstitution/dilution has taken place in controlled and validated aseptic conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is esmolol hydrochloride.
One 50 ml vial contains 2500 mg esmolol hydrochloride. The product contains no other ingredients.
Each ml of reconstituted concentrate for solution for infusion contains 50 mg esmolol hydrochloride (50 mg/ml).
Each ml of the diluted solution for infusion contains 10 mg esmolol hydrochloride (10 mg/ml).
One vial contains 2500 mg white to almost white powder.
The vial consists of colourless glass (type I).
One pack ESMOLOL HYDROCHLORIDE 2500 mg powder for solution for infusion contains 1 vial.
Marketing Authorisation Holder
Manufacturer
This medicinal product is authorised in the Member States of the EEA under the following names:
Belgium: ESMOCARD 2500 mg Poudre pour solution à diluer pour solution pour perfusion
Czech Republic: ESMOCARD LYO 2500 mg prášek pro koncentrát pro infuzní roztok
Denmark: ESMOCARD LYO 2500 mg Pulver til koncentrat til infusionsvæske, opløsning
Finland: ESMOCARD 2500 mg Kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos
France: ESMOCARD 2500 mg Poudre pour solution à diluer pour solution pour perfusion
Germany: ESMOCARD LYO 2500 mg Pulver zur Herstellung einer Infusionslösung
Greece: ESMOCARD LYO 2500 mg κόνις για πυκνό σκεύασμα για παρασκευή διαλύματος προς έγχυση
Hungary: ESMOCARD LYO 2500 mg por oldatos infúzióhoz való koncentrátumhoz
Ireland: ESMOCARD LYO 2500 mg powder for concentrate for solution for infusion
Italy: ESMOCARD 2500 mg polvere per concentrato per soluzione per infusione
Netherlands: Esmolol HCl LYO Orpha 2500 mg poeder voor concentraat voor oplossing voor infusie
Poland: ESMOCARD LYO 2500 mg proszek do sporządzania koncentratu roztworu do infuzji
Slovak Republic: ESMOCARD LYO 2500 mg prášok na infúzny koncentrát
Slovenia: ESMOCARD LYO 2500 mg prašek za koncentrat za raztopino za infundiranje
Sweden: ESMOCARD 2500 mg Pulver till koncentrat till infusionsvätska, lösning
United Kingdom: ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion
This leaflet was last revised in September 2021.